A bivalent human papillomavirus (HPV)-16/18 L1 virus-like particle AS04 vaccine may not increase viral clearance

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1601, 2007-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AS04-adjuvanted human papillomavirus types 16/18 vaccine (Cervarix®): a guide to its use

By Lyseng-Williamson Katherine A. McKeage Kate

Drugs & Therapy Perspectives, Vol. 28, Iss. 3, 2012-03 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

By McKeage Kate

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 465-468

Adis International

Access to resources Recommend Favorite

Human papillomavirus (HPV) vaccine prevents cervical precancers and noninvasive cervical cancers

Inpharma, Vol. 1, Iss. 1509, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Rational Design of a Stable, Freeze-Dried Virus-Like Particle-Based Vaccine Formulation

By Lang R. Winter G. Vogt L. Zurcher A. Dorigo B. Schimmele B.

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 1, 2009-01 ,pp. : 83-97

Informa Healthcare

Access to resources Recommend Favorite

HPV 16/18 vaccine prevents cervical intraepithelial neoplasia

Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite